In a Canadian research-peptide context, FOXO4-DRI sits within the longevity class of reference standards. This post collects what HPLC-verified labs need to source, store, and reproducibly use this material, sourced from public literature and Lumera's published lot history.
Why FOXO4-DRI matters
The Baar et al. 2017 paper, the dominant-interfering retro-inverso design, and what senolytic-research labs should know. The reproducibility gap on most catalogs comes from one place: lots that don't hit ≥ 99% HPLC purity get sold at lower price points instead of being rejected. Lumera's published purity floor is 99.0%, with the average across the catalog at 99.18%. Every lot we ship has a Janoshik-Analytical-verified COA archived publicly at /lab-results/ from synthesis onwards.
The protocol short-version
For Canadian research labs working with FOXO4-DRI, the lifecycle is: receive the cold-chain-shipped vial at −20 °C, transfer immediately to a research-grade −20 °C freezer, reconstitute in sterile bacteriostatic water at the working concentration your protocol specifies, and use within the storage window noted on the lot's COA. Avoid repeated freeze-thaw cycles — every cycle introduces measurable assay drift even on lots that meet the purity floor.
Cross-batch reproducibility
Lumera holds a 5-year retain sample on every lot. If your assay drifts, we run our retain against your in-hand material and pinpoint whether the variance is in the peptide or upstream in your reagent pipeline. This is the most-requested feature labs cite when asked why they reorder.
Where to source it in Canada
Lumera Labs is Kelowna-based and ships cold-chain Xpresspost across Canada. Free shipping over $200 CAD; flat $25 below that. Browse the catalog at /products/ or build a multi-peptide protocol via the Stack Builder with auto-applied 5/10/15% volume discounts at 2/3/4+ vials. Read more on cold-chain handling in our shipping note, lot verification at /coa-verify/, or the public lot archive at /lab-results/.